These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20039954)

  • 1. Resolution of menstrually related migraine following aggressive treatment for breast cancer.
    Smitherman TA; Kolivas ED
    Headache; 2010 Mar; 50(3):485-8. PubMed ID: 20039954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menstrual migraine: case studies of women with estrogen-related headaches.
    Hutchinson SL; Silberstein SD
    Headache; 2008; 48 Suppl 3():S131-41. PubMed ID: 19076659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced breast cancer: How much chemotherapy is enough?
    DiPaola RS; Kaufman A; Mikhail MM
    Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
    [No Abstract]   [Full Text] [Related]  

  • 5. Sex hormones and headache.
    Silberstein SD
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S30-41. PubMed ID: 11139745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nuclear receptors--watchful mistrust of tamoxifen].
    Dingermann T; Zündorf I
    Pharm Unserer Zeit; 2004; 33(5):350-1. PubMed ID: 15497327
    [No Abstract]   [Full Text] [Related]  

  • 7. [Menstrual migraine].
    Vetvik KG; Russell MB
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2575-8. PubMed ID: 19023354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen, raloxifene and the prevention of breast cancer.
    Bentrem DJ; Craig Jordan V
    Minerva Endocrinol; 2002 Jun; 27(2):127-39. PubMed ID: 11961504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal management of migraine associated with menses and the menopause: a clinical review.
    Loder E; Rizzoli P; Golub J
    Headache; 2007 Feb; 47(2):329-40. PubMed ID: 17300386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
    Nett R; Mannix LK; Mueller L; Rodgers A; Hustad CM; Skobieranda F; Ramsey KE
    Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and biology of menstrual migraine.
    Martin VT; Lipton RB
    Headache; 2008; 48 Suppl 3():S124-30. PubMed ID: 19076658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early experiences of breast-conservation treatment combined with tamoxifen and CAF chemotherapy for breast cancer of stages I and II.
    Ogawa Y; Nishioka A; Inomata T; Hamada N; Terashima M; Yoshida S; Tanaka Y; Ogoshi S; Araki K; Kumon M
    Radiat Med; 1994; 12(1):29-35. PubMed ID: 8016401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen in ductal carcinoma in situ.
    Daly MB
    Semin Oncol; 2006 Dec; 33(6):647-9. PubMed ID: 17145343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy].
    Jiang Z; Song S; Liu X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):420-2. PubMed ID: 11810777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.
    Mathew J; Agrawal A; Asgeirsson KS; Buhari SA; Jackson LR; Cheung KL; Robertson JF
    Breast Cancer Res Treat; 2009 Jan; 113(2):403-7. PubMed ID: 18311583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):495S-501S. PubMed ID: 12538506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of irradiation of the internal mammary lymph nodes in high-risk stage II to IIIA breast cancer patients after high-dose chemotherapy: a prospective sequential nonrandomized study.
    Stemmer SM; Rizel S; Hardan I; Adamo A; Neumann A; Goffman J; Brenner HJ; Pfeffer MR
    J Clin Oncol; 2003 Jul; 21(14):2713-8. PubMed ID: 12860949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hormonal therapy on cognitive functioning in breast cancer patients: a review of the literature.
    Schilder CM; Schagen SB
    Minerva Ginecol; 2007 Aug; 59(4):387-401. PubMed ID: 17923830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoadjuvant antihormonal treatment of women with breast cancer].
    Tuxen MK; Kamby C; Nielsen DL
    Ugeskr Laeger; 2007 Sep; 169(37):3077-81. PubMed ID: 17877952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.